Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer (NCT00237900) | AstraZeneca | 2003-07-01 |
Track Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC automatically
Every clearance here is in the API, with alerts when new ones post.